Choose a language and wait for the translated text.
miRecule has signed a research collaboration with Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted RNA therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
